Management ChangeApr 23, 2026, 05:12 PM
Avantor Appoints Ludovic Brellier as EVP & CTO; Gourdier to Depart
AI Summary
Avantor, Inc. announced the appointment of Ludovic Brellier as Executive Vice President, Bioscience and Medtech Products and Chief Transformation Officer, effective May 1, 2026. This strategic hire aims to support the company's integration activities. Concurrently, Benoit Gourdier, the former Executive Vice President, Bioscience and Medtech Products, will transition to a new role supporting segment integration before his expected departure from the company by December 31, 2026.
Key Highlights
- Ludovic Brellier appointed Executive Vice President, Bioscience and Medtech Products and Chief Transformation Officer.
- Brellier's new role is effective May 1, 2026.
- Benoit Gourdier transitions from Executive Vice President, Bioscience and Medtech Products.
- Gourdier is expected to depart the company by December 31, 2026.
Price Impact
More from AVTR